Research programme: iron supplementation therapeutics - Viramal
Latest Information Update: 14 Mar 2024
Price :
$50 *
At a glance
- Originator Viramal
- Class Antianaemics; Iron compounds
- Mechanism of Action Iron replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Iron deficiency anaemia
Most Recent Events
- 28 Feb 2024 Preclinical trials in Iron deficiency anaemia in United Kingdom (Buccal) prior to February 2024 (Viramal pipeline, February 2024)
- 28 Feb 2024 Preclinical trials in Iron deficiency anaemia in United Kingdom (Transdermal) prior to February 2024 (Viramal pipeline, February 2024)